Here are 25 key notes on orthopedic and spine device companies over the past week.
Alphatec Holdings, the parent company of Alphatec Spine, recently appointed Donald A. Williams as the chairman of the Audit Committee.
Amedica shares saw a significant 39.7 percent growth in short interest in November.
Aurora Spine's net sales increased by 116 percent in the third quarter 2015, compared to the third quarter 2014.
AxioMed is bringing its cervical viscoelastic total disc replacement to the United States.
Bioventus completed its acquisition of BioStructures.
CONMED signed a definitive agreement to acquire SurgiQuest for $265 million on a cash-free, debt-free basis.
Cytos Biotechnology and Kuros Biosurgery intend to combine their business.
Ellipse Technologies filed an S-1 to raise $75 million through an initial public offering.
Dr. Buch — the first and only surgeon who has been approved to use any of Implantcast's implants in the United States — has performed eight knee and humorous surgeries using the implants.
InVivo Therapeutics plans to create Bioengineered Neural Trails to treat patients with chronic spinal injuries.
InVivo Therapeutics has final safety claim for a pivotal study and a new licensing agreement.
Zacks downgraded Mazor Robotics shares to a "hold" rating.
MEDTECH sold its first ROSA robot in the United Kingdom.
MiMedx received 12 new patents year-to-date in 2015 from the U.S. Patent and Trademark Office.
Mobelife will collaborate with Exactech Australia to bring the company's custom orthopedic implants to the Australian market.
Moximed's Atlas Knee System received the CE Mark approval.
Orthobiologics company OrthoSera launched the BoneAlbumin for musculoskeletal indications.
NuVasive elected Jason D. Hanson as the company's executive vice president, strategy, corporate development and general counsel.
SI-BONE recently closed a $39.2 million credit facility with Oxford Finance and Silicon Valley Bank.
St. Jude Medical received FDA approval and launched the Proclaim Elite Spinal Cord Stimulation System in Europe.
VEXIM named Steve Swinson the new chairman of its board of directors.
Kent Swanson, a director of Xtant Medical, bought 5,000 company shares in a recent transaction.
Xtant Medical's subsidiary Bacterin developed a three-dimensional printer that can prototype custom, resorbable bone grafts for reconstructive procedures.
Xtant Medical's wholly owned subsidiary, X-spine Systems received FDA clearance for expanded indications to include ilium fixation and extended length screws for the Fortex and the Xpress 2 Pedicle Screw System.
The FDA's safety claim for Zimmer's injection indicates the product is safe to use in repeat treatments for knee osteoarthritis patients.